1445365: CHLORDIAZEPOXIDE HYDROCHLORIDE C.
CHLORDIAZEPOXIDE HYDROCHLORIDE C. Key specifications include administration: ORAL, capsule_content_form: POWDER, primary_container_type: BOTTLE, protective_storage_feature: CONTROLLED ROOM TEMPERATURE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, controlled_substance_classification: SCHEDULE IV. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-660-4989, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| capsule_content_form | POWDER |
| primary_container_type | BOTTLE |
| protective_storage_feature | CONTROLLED ROOM TEMPERATURE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| controlled_substance_classification | SCHEDULE IV |
| active_medicament_medicinal_strength | 5.0 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | LIBRIUM (CHLORDIAZEPOXIDE HCL) 5 MG CAPSULE, 100S |
| capsule_primary_container_content_quantity | 100.0 |
| NSN | 6505-01-660-4989 |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| ADMINISTRATION | ORAL |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | EACH CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE CONTAINS 5 MILLIGRAMS (MG) OF THE ACTIVE INGREDIENT; PACKAGED IN BOTTLES OF 100 CAPSULES; DEA SCHEDULE DRUG CLASS IV; STORE AT 20 TO 25 C (68 TO 77 F); (SEE USP CONTROLLED ROOM TEMPERATURE) |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.0 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIBRIUM (CHLORDIAZEPOXIDE HCL) 5 MG CAPSULE, 100S |
| CAPSULE CONTENT FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.0 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |